[go: up one dir, main page]

AU2012262554A8 - Extracellular matrix material conduits and methods of making and using same - Google Patents

Extracellular matrix material conduits and methods of making and using same

Info

Publication number
AU2012262554A8
AU2012262554A8 AU2012262554A AU2012262554A AU2012262554A8 AU 2012262554 A8 AU2012262554 A8 AU 2012262554A8 AU 2012262554 A AU2012262554 A AU 2012262554A AU 2012262554 A AU2012262554 A AU 2012262554A AU 2012262554 A8 AU2012262554 A8 AU 2012262554A8
Authority
AU
Australia
Prior art keywords
methods
extracellular matrix
making
same
matrix material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2012262554A
Other versions
AU2012262554B2 (en
AU2012262554A1 (en
Inventor
Robert G. Matheny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cormatrix Cardiovascular Inc
Original Assignee
Cormatrix Cardiovascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cormatrix Cardiovascular Inc filed Critical Cormatrix Cardiovascular Inc
Publication of AU2012262554A1 publication Critical patent/AU2012262554A1/en
Publication of AU2012262554A8 publication Critical patent/AU2012262554A8/en
Application granted granted Critical
Publication of AU2012262554B2 publication Critical patent/AU2012262554B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415—Manufacturing methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2103/05—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Manufacturing & Machinery (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Extracellular matrix (ECM) material conduits are disclosed. Methods for regenerating atrioventricular valves to replace defective atrioventricular valves within a heart of a subject using the ECM material conduits are also disclosed. Methods of sterilizing and decellularizing an ECM material are also disclosed.
AU2012262554A 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same Ceased AU2012262554B2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201161490873P 2011-05-27 2011-05-27
US201161490693P 2011-05-27 2011-05-27
US61/490,873 2011-05-27
US61/490,693 2011-05-27
US201161491723P 2011-05-31 2011-05-31
US61/491,723 2011-05-31
US201261650911P 2012-05-23 2012-05-23
US61/650,911 2012-05-23
PCT/US2012/039450 WO2012166554A2 (en) 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same

Publications (3)

Publication Number Publication Date
AU2012262554A1 AU2012262554A1 (en) 2013-11-28
AU2012262554A8 true AU2012262554A8 (en) 2014-02-27
AU2012262554B2 AU2012262554B2 (en) 2016-09-15

Family

ID=47260207

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012262554A Ceased AU2012262554B2 (en) 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same

Country Status (8)

Country Link
JP (2) JP2014519379A (en)
KR (1) KR20140145954A (en)
AU (1) AU2012262554B2 (en)
BR (1) BR112013030482A2 (en)
CA (1) CA2835859A1 (en)
IL (1) IL229287B (en)
SG (1) SG194878A1 (en)
WO (1) WO2012166554A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012166549A1 (en) 2011-05-27 2012-12-06 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
WO2014133543A1 (en) * 2013-03-01 2014-09-04 Cormatrix Cardiovascular, Inc. Two-piece prosthetic valve
EP3796876B1 (en) 2018-05-22 2022-07-27 Boston Scientific Scimed, Inc. Percutaneous papillary muscle relocation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4790844A (en) * 1987-01-30 1988-12-13 Yoel Ovil Replacement of cardiac valves in heart surgery
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
AU662342B2 (en) * 1991-05-16 1995-08-31 3F Therapeutics, Inc. Cardiac valve
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5713950A (en) * 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
US5480424A (en) 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
JP2001505807A (en) * 1996-12-10 2001-05-08 パーデュー・リサーチ・ファウンデーション Artificial vascular valve
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
US6579538B1 (en) 1999-12-22 2003-06-17 Acell, Inc. Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof
US7033611B2 (en) 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
US7331993B2 (en) * 2002-05-03 2008-02-19 The General Hospital Corporation Involuted endovascular valve and method of construction
US7550004B2 (en) * 2002-08-20 2009-06-23 Cook Biotech Incorporated Endoluminal device with extracellular matrix material and methods
US7087034B2 (en) * 2002-09-19 2006-08-08 Mcpherson William E Vascular shunt with audio flow indication
CO5500017A1 (en) * 2002-09-23 2005-03-31 3F Therapeutics Inc MITRAL PROTESTIC VALVE
US7108832B2 (en) 2003-06-23 2006-09-19 Novasterilis Inc. Sterialization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
DE10340265A1 (en) * 2003-08-29 2005-04-07 Sievers, Hans-Hinrich, Prof. Dr.med. Prosthesis for the replacement of the aortic and / or mitral valve of the heart
JP2007105081A (en) * 2005-10-11 2007-04-26 Japan Health Science Foundation Decellularization of living tissue for transplantation with supercritical carbon dioxide
US20090157177A1 (en) * 2007-12-18 2009-06-18 Matheny Robert G Sewing Ring for a Prosthetic Tissue Valve

Also Published As

Publication number Publication date
JP2014519379A (en) 2014-08-14
AU2012262554B2 (en) 2016-09-15
KR20140145954A (en) 2014-12-24
WO2012166554A2 (en) 2012-12-06
WO2012166554A3 (en) 2014-05-08
IL229287B (en) 2019-05-30
CA2835859A1 (en) 2012-12-06
SG194878A1 (en) 2013-12-30
JP2017060776A (en) 2017-03-30
IL229287A0 (en) 2014-01-30
AU2012262554A1 (en) 2013-11-28
BR112013030482A2 (en) 2016-09-27
WO2012166554A8 (en) 2014-01-23

Similar Documents

Publication Publication Date Title
IL265470B (en) Culture medium composition, and method for culturing cell or tissue using said composition
EP2663258A2 (en) Prosthetic valve for replacing an atrioventricular heart valve
AU2011372711B2 (en) Method for processing mesenchymal stem cells and the use thereof in the treatment of diseases associated with oxidative stress
AU2013289661A8 (en) Decellularization method for preparing extracellular matrix support material
MX2013001045A (en) Liver organoid, uses thereof and culture method for obtaining them.
MX2013008850A (en) Compositions and methods for treating cardiovascular diseases.
EP2588592A4 (en) USE OF DECELLULARIZED ORGANS BY PERFUSION IN ADAPTED RECELLULARIZATION
EP4406514A3 (en) Aortic bioprosthesis and systems for delivery thereof
BR112013032229A2 (en) hydrothermal hydrothermal biomass treatment method, and, composition
SG10201906304TA (en) Use of perfusion decellularized liver for islet cell recellularization
MY166059A (en) Fusion Proteins for Treating Metabolic Disorders
MX349171B (en) Methods and systems for harvesting cells.
PH12014501427A1 (en) Anti-php-tau antibodies and their uses
EP2646543A4 (en) METHOD FOR GENERATING CORNEAL CELLS AND CELL POPULATIONS COMPRISING THE SAME
BR112013027307A2 (en) method for treating a tissue matrix; acellular tissue matrix
WO2013070881A8 (en) Method for elimination of space through tissue approximation
MY194587A (en) Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
GB2511600A (en) Methods for performing patterned chemistry
EP3090704A4 (en) Method for preparing artificial heart valve leaflets
AU2012248333A2 (en) Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
UY34070A (en) METHOD AND COMPOSITION FOR SEED TREATMENT.
AU2012339701A8 (en) Autoclavable suspensions of cyclosporin A Form 2
AU2012262554A8 (en) Extracellular matrix material conduits and methods of making and using same
WO2012112757A3 (en) Compositions and improved soft tissue replacement methods
MY161163A (en) Culture medium for human mesenchymal stem cells

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 27 , NO 46 , PAGE(S) 6582 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME CORMATRIX CARDIOVASCULAR, INC., APPLICATION NO.2012262554, UNDER INID (31), INSERT 61/650,911; UNDER INID (32) INSERT THE DATE 23.05.12; UNDER INID (33) INSERT US

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired